Left middle cerebral artery territory infarction due to intravitreal injection of ranibizumab

Left middle cerebral artery territory infarction due to intravitreal injection of ranibizumab

Intravitreal injection of anti-vascular endothelial growth factor (VEGF) agents is increasingly used for the treatment of a wide variety of retinal diseases including age-related macular degeneration, diabetic retinopathy and retinal vascular occlusions, and retinopathy of prematurity. Despite encou...

Full description

Bibliographic Details
Main Authors: Shambo Samrat Samajdar, Shatavisa Mukherjee, Sukalyan Saha Roy, Santanu Kumar Tripathi
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2018-01-01
Series:TNOA Journal of Ophthalmic Science and Research
Subjects:
adverse effects
anti-vascular endothelial growth factor agents
ranibizumab
thromboembolic complications
Online Access:http://www.tnoajosr.com/article.asp?issn=2589-4528;year=2018;volume=56;issue=3;spage=191;epage=193;aulast=Samajdar

Internet

http://www.tnoajosr.com/article.asp?issn=2589-4528;year=2018;volume=56;issue=3;spage=191;epage=193;aulast=Samajdar

Similar Items